Phosphoramidate Based Antisense Inhibitors Nf-Kb

Nerenberg, Michael I.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Small Business Technology Transfer (STTR) Grants - Phase I (R41)
• Project #: 1R41CA071143-01
• Application #: 2009915
• Study Section: Special Emphasis Panel (ZRG7-SSS-2 (21))
• Project Start: 1996-09-15
• Project End: 1998-04-30
• Budget Start: 1996-09-15
• Budget End: 1998-04-30
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Lynx Therapeutics, Inc.
• City: Hayward
• State: CA
• Country: United States
• Zip Code: 94545

Publications

Wang, L; Gryaznov, S; Nerenberg, M (1999) Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates. Inflammation 23:583-90